Brewin Dolphin LTD Arrowhead Pharmaceuticals, Inc. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Nov 09, 2023
SELL
$20.56 - $63.12 $36,391 - $111,722
-1,770 Closed
0 $0
Q4 2019

Nov 09, 2023
BUY
$28.14 - $73.01 $49,807 - $129,227
1,770 New
1,770 $112 Million
Q1 2019

Nov 09, 2023
SELL
$12.05 - $20.18 $23,798 - $39,855
-1,975 Closed
0 $0
Q3 2018

Nov 09, 2023
BUY
$14.0 - $20.3 $27,650 - $40,092
1,975 New
1,975 $37.9 Million

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
92.3M
Call Options Held
1.33M
Put Options Held
549K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email